Settlement
Roche, Biogen end patent dispute over Actemra biosimilar
Roche has swiftly resolved a patent infringement lawsuit it initiated against Biogen in July. The legal dispute centered around Biogen’s ...
Indivior ends Suboxone saga with $385M antitrust deal
Indivior, the manufacturer of Suboxone, has taken a significant step towards closing the chapter on years of antitrust litigation related ...
Pfizer agrees to pay $300,000 to resolve gender pay bias claims at NYC HQ
Pfizer has agreed to a $2 million settlement to resolve allegations made by the US Department of Labor, which claimed ...
Mallinckrodt gets court approval for second bankruptcy, reducing opioid settlement by $1B
Mallinckrodt’s commitment to pay a hefty $1.7 billion opioid settlement has taken a significant hit due to the company’s second ...
Takeda reaches settlement with drug wholesalers over alleged pay-for-delay scheme for Colcrys
Takeda, the Japanese pharmaceutical giant, has reached a settlement in an antitrust case that has been looming over the company. ...
Alexion settles Soliris sales practices lawsuit for $125 million
After nearly seven years since the departure of Alexion’s CEO and CFO amidst an investigation into improper sales practices, the ...
Walgreens to pay $44 million to customers who bought faulty Theranos blood tests
Walgreens has reached a settlement in a long-running class-action case related to patients who underwent fraudulent blood tests provided by ...
3M Reaches Historic Settlement: The Sound of Justice Rings Louder
3M, the manufacturing giant, has concluded a chapter that involved battling allegations of knowingly distributing defective earplugs to the US ...
Following $1.7B Opioid Settlement, Mallinckrodt Prepares for Second Round of Bankruptcy Proceedings
In a recent development, Mallinckrodt has formally announced its decision to initiate another round of bankruptcy proceedings, marking its second ...
Nine States Pushback Against Lilly’s $13.5M Insulin Pricing Settlement
In a dramatic legal showdown, nine states are raising objections to a potentially game-changing $13.5 million settlement that pharmaceutical giant ...
Teva sets aside $200 million in ‘advanced’ settlement negotiations to end the US price-fixing investigation
Teva, a pharmaceutical company facing a price-fixing indictment by the U.S. Department of Justice (DOJ), is taking steps to resolve ...
Teva Aims for Growth by 2027 After $4.25B Opioid Settlement
Teva Pharmaceutical is shifting its focus back to its core businesses in generics and biosimilars, seeing promising opportunities in both ...
